IgG Antibodies to GlcNAc<i>β</i> and Asialo-GM2 (GA2) Glycans as Potential Markers of Liver Damage in Chronic Hepatitis C and the Efficacy of Antiviral Treatment.

Dis Markers · 2018 · PMC6304914 · PMID 30627223

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a marginal trendno p-value reported

The level of other AG Abs was not associated with fibrosis stages or exhibited a marginal trend to association.

also in 626 other papers

a weak trendno p-value reported

The mean value of the anti- α Gal IgG level in patients with fibrosis was increased ( Figure 1 ), but we observed only a weak trend to the higher level of anti- α Gal Abs in fibrosis.

also in 1,404 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.